Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-762-5 | CAS number: 12672-27-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable well documented publication which meets basic scientific principles.
Data source
Reference
- Reference Type:
- publication
- Title:
- Effects of cobalt sulfate on prenatal development of mice, rats, and rabbits, and on early postnatal development of rats.
- Author:
- Szakmary, E. et al.
- Year:
- 2 001
- Bibliographic source:
- Journal of Toxicology and Environmental Health, Part A 62: 367-386
Materials and methods
- Principles of method if other than guideline:
- The effects of cobalt(II)sulfate heptahydrate administered to pregnant rats were studied on fetal and postnatal offspring.
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- 10026-24-1
- EC Number:
- 600-050-9
- Cas Number:
- 10026-24-1
- IUPAC Name:
- 10026-24-1
- Reference substance name:
- cobalt(II)sulfate heptahydrate
- IUPAC Name:
- cobalt(II)sulfate heptahydrate
- Details on test material:
- - Name of test material (as cited in study report): Cobalt(II)sulfate heptahydrate (CoSO4x7H2O, CAS 10026-24-1, REANAL Budapest)
- Analytical purity: no data
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: LATI, Gödöllö
- Weight at study initiation: 200-240 g
- Housing: plastic cages, on steam-sterilized, hardwood shavings
- Diet (ad libitum): standard rat pellets
- Water (ad libitum): tap water
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 40-70
- Air changes (per hr): 10
- Photoperiod: 0600-0800 dim light; 0800-1800 daylight; 1800-2000 dimlight; 2000-0600 darkness
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on exposure:
- Doses of cobalt(II)sulfate heptahydrate per kilogram body weight were dissolved in 10 mL tap water for rats.
- Analytical verification of doses or concentrations:
- not specified
- Details on mating procedure:
- Rats were mated in harem system: Males were placed among the females overnight. Vaginal smears were taken daily and stained with 1% methylene blue solution. The day when sperm were found in the vaginal smear of females in estrus was regarded as the first day of gestation.
- Duration of treatment / exposure:
- 1) GD 1-20
2) single exposure to pregnant rats
3) single exposure on GD 20
4) single exposure on GD 16
5) GD 1-21 - Frequency of treatment:
- Experiment 1 and 5: once daily
- Duration of test:
- up to ~ 3 weeks
Doses / concentrations
- Remarks:
- Doses / Concentrations:
1) 0, 25, 50, 100 mg/kg; 2) 100 mg/kg; 3) 0, 100, 200, 300 mg/kg; 4) 0, 0.0625, 0.125, 0.250 mg/kg; 5) 0, 25 mg/kg
Basis:
other: nominal conc., calculated as the anhydrous salt of cobalt(II) sulfate heptahydrate
- No. of animals per sex per dose:
- 1) 3
2) 6
3) 6
4) 3
5) no data - Control animals:
- yes
- Details on study design:
- 1) Cobalt concentration was determined by atomic absorption spectrometry in samples of maternal and fetal blood as well as in amniotic fluid taken at the time of the treatment on day 20 and 24 hours after that.
2) Cobalt concentration was determined by atomic absorption spectrometry in blood samples taken at 0, 1, 2, or 3 hours after the treatment.
3) Cobalt concentration was determined by atmoic absorption spectrometry in blood samples taken at 0, 2, 4, 8, 12, or 24 hours after the treatment.
4) Rats were anesthetized on day 16 of gestation; the uterus was exposed and the fetuses were treated intra-amnially with the test substance. The dams were exsanguinated under ether narcosis 24 hours later.
5) Dams were allowed to give birth.
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: No data
DETAILED CLINICAL OBSERVATIONS: No data
BODY WEIGHT and Body weight gain: Yes
FOOD CONSUMPTION: Yes
- Time schedule for examinations: daily
WATER CONSUMPTION: Yes
- Time schedule for examinations: daily
Autopsy and Histological Examinations:
Findings at autopsy were recorded. Weights of brain, hypophysis, thymus, lungs, heart, liver, spleen, kidneys, adrenals, and ovaries were measured and the relative organ weights were calculated. Histological examination was performed on the excised oragns, the stomach and uterus. Furthermore, all pathologic alterations found in any of the animals were examined histologically (fixation in 4% neutralized formaldehyde, embedding in paraffin, slicing sections of 6 μm, and staining with HE).
Clinical Laboratory tests:
Blood samples were taken from the aorta under ether anesthesia: complete blood cell counts, hemoglobin concentration, mean cell volume (MCV), mean cell hemoglobin (MCH), and mean cell hemoglobin concentration (MCHC) values, blood glucose, serum urea nitrogen, creatinine, bilirubin, albumin, serum alkaline phosphate, and aspartate aminotransferase (ASAT) and alanine aminotransferase (ALAT) activities. - Fetal examinations:
- The perinatal [(number of live pups on day 5 / number of live newborns)x100] and the survival index [(number of live pups on day 21 / number of live pups on day 5)x100] were determined. The perinatal and postnatal development of the pups was followed up to postnatal day 21. The total litter size (live and dead pups) was determined and the body weight of the pups was measured on postnatal day 1, 7, 14, and 21. Further, the days of descending of testes, forming of ears, breakthrough of the teeth, and opening of the eyes were recorded.
For monitoring the development of the nervous system, the development of forward movement and swimming was examined according to (Vorhees et al., 1979), and the righting reflex was examined according to (Brunner et al., 1978). The development of muscle strength was also monitored, with remaining on a tilted plane as the parameter according to (Paksy et al., 1982) and cliff avaoidance according to (Brunner et al., 1978). All examinations were carried out on postnatal day 1-21, at times indicated, on 2 male and 2 female pups from each litter. - Statistics:
- The litter was regarded as the statistical unit. Parametric data (maternal organ weights, clinical and biochemical parameters, food and fluid consumption, fetal and placental weights) of groups were compared using analysis of variance and the Dunnett test, while nonparametric variables (frequencies of pre- and post-implantational losses, frequencies of body weight, skeletal and internal organ retardations, minor and major anomalies) of groups were compared using a Kruskall-Wallis test. The level of significance was chosen to be 5%.
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Details on maternal toxic effects:
Daily food consumption was 1010-1200 J/kg bw in the control group and 790-990 J/kg bw in the group treated with the highest cobalt dose. Cobalt sulfate did not significantly affect maternal weight gain. At the highest dosage, the relative weights of liver, adrenals, and spleen were increased, but not significantly. Significantly increased urea nitrogen and creatinine concentrations and significantly decreased albumin and glucose concentration in the serum or blood were determined. Pathologic histological alterations were not observed in any of the dose groups.
The number of mothers that died during delivery rose in proportion to the increase of doses of cobalt sulfate (0/15, 1/15, 5/15, 12/20 corresponding to 0, 25, 50 and 100 mg/kg bw).
Effect levels (maternal animals)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 50 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: maternal toxicity
- Dose descriptor:
- NOAEL
- Effect level:
- 10.5 mg/kg bw/day
- Based on:
- element
- Remarks:
- Co
- Basis for effect level:
- other: maternal toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:yes
Details on embryotoxic / teratogenic effects:
The frequency of fetuses with retarded body weight and skeletal and visceral retardation significantly increased with the dose of cobalt sulfate. The two higher doses increased the frequency of malformations of skeleton (cranium, vertebrae) and the urogenital system (dilated renal pelvis and ureter, dystopic ovaries and testes) was predominatly affected.
Cobalt salt administered into the amnion proved to be embryotoxic. The frequency of dead fetuses increased and the body weight of the live fetuses decreased. No histopathological changes were found in the live fetuses in the uterus, while the fetuses that died in the uterus showed extensive necrotic, necrobiotic changes of the skin and the parenchymal organs.
The perinatal index decreased significantly from the value of 92.0 ± 7.0 in the control group to 73.3 ± 8.8 following cobalt sulfate treatment. The survival index was not significantly affected.
The body weight of the newborn animals was significantly smaller in the treated group compared to the control on postnatal day 1 and 7, while on postnatal day 14 and 21 there was no difference between the groups.
Eye opening was completed in the usual time period in both groups, while time of appearance of the teeth, descending of the testes, shaping of ears, and development of hearing was delayed in the treated group. The development of muscle strength and of the locomotor system was delayed. All the functions studied (forward movement, swimming, righting reflex) normalized by postnatal day 21, with the exception of muscle strength.
The frequency of fetuses with retarded body weight and skeletal and visceral retardation significantly increased with the dose of cobalt sulfate. The two higher doses increased the frequency of malformations of the skeleton (cranium, vertebrae) and the urogenital system (dilated renal pelvis and ureter, dystopic ovaries and testes) was predominantly affected.
Effect levels (fetuses)
open allclose all
- Dose descriptor:
- LOAEL
- Effect level:
- 25 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: embryotoxicity
- Dose descriptor:
- LOAEL
- Effect level:
- 5.2 mg/kg bw/day
- Based on:
- element
- Remarks:
- Co
- Basis for effect level:
- other: embryotoxicity
- Dose descriptor:
- LOAEL
- Effect level:
- 25 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: teratogenicity
- Dose descriptor:
- LOAEL
- Effect level:
- 5.2 mg/kg bw/day
- Based on:
- element
- Remarks:
- Co
- Basis for effect level:
- other: teratogenicity
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
Cobalt concentration in the maternal blood was increased in proportion to the administered doses. Cobalt crossed the placenta and appeared in the fetal blood and amniotic fluid. Regardless of the administered dose of cobalt sulfate, cobalt concentration in the blood peaked 2 hours after administration.
Applicant's summary and conclusion
- Conclusions:
- It is concluded that cobalt sulfate exposure decreases the perinatal viability of the fetuses, but the functions of the surviving fetuses with perinatal retardation become compensated by postnatal week 2-3. The development of fetuses is undisturbed thereafter.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.